ADVFN
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Endonovo Therapeutics Inc (PK)

Endonovo Therapeutics Inc (PK) (ENDV)

0.0001
-0.00008
(-44.44%)

Endonovo Therapeutics Inc (PK) (ENDV) Quote

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.0001
( -44.44% )
Bid
0.0001
Ask
0.0003
Volume
50,600
0.0001 Day's Range 0.0001
0.0001 52 Week Range 0.0019
Market Cap
Previous Close
0.00018
Open
0.0001
Last Trade
50499
@
0.0001
Last Trade Time
Financial Volume
$ 5
VWAP
0.0001
Average Volume (3m)
5,531,956
Shares Outstanding
396,830,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.01
Revenue
10k
Net Profit
-2.8M

About Endonovo Therapeutics Inc (PK)

Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Thera... Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
Wilmington, Delaware, USA
Founded
-
Endonovo Therapeutics Inc (PK) is listed in the Electromedical Apparatus sector of the OTCMarkets with ticker ENDV. The last closing price for Endonovo Therapeutics (PK) was $0. Over the last year, Endonovo Therapeutics (PK) shares have traded in a share price range of $ 0.0001 to $ 0.0019.

Endonovo Therapeutics (PK) currently has 396,830,000 shares outstanding. The market capitalization of Endonovo Therapeutics (PK) is $71,429.40 . Endonovo Therapeutics (PK) has a price to earnings ratio (PE ratio) of 0.00.

ENDV Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00010.00030.000114233520.00023927CS
4-5.0E-5-33.33333333330.000150.00030.000117913600.00020776CS
12-0.00014-58.33333333330.000240.00030.000155319560.00020313CS
26-0.0002-66.66666666670.00030.00040.0001177786210.00023083CS
52-0.0009-900.0010.00190.0001126279940.00033907CS
156-0.0099-990.010.0280.000144770670.00085054CS
260-0.09865-99.89873417720.098750.14950.000127137710.00248175CS

ENDV - Frequently Asked Questions (FAQ)

What is the current Endonovo Therapeutics (PK) share price?
The current share price of Endonovo Therapeutics (PK) is $ 0.0001
How many Endonovo Therapeutics (PK) shares are in issue?
Endonovo Therapeutics (PK) has 396,830,000 shares in issue
What is the market cap of Endonovo Therapeutics (PK)?
The market capitalisation of Endonovo Therapeutics (PK) is USD 71.43k
What is the 1 year trading range for Endonovo Therapeutics (PK) share price?
Endonovo Therapeutics (PK) has traded in the range of $ 0.0001 to $ 0.0019 during the past year
What is the reporting currency for Endonovo Therapeutics (PK)?
Endonovo Therapeutics (PK) reports financial results in USD
What is the latest annual turnover for Endonovo Therapeutics (PK)?
The latest annual turnover of Endonovo Therapeutics (PK) is USD 10k
What is the latest annual profit for Endonovo Therapeutics (PK)?
The latest annual profit of Endonovo Therapeutics (PK) is USD -2.8M
What is the registered address of Endonovo Therapeutics (PK)?
The registered address for Endonovo Therapeutics (PK) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Endonovo Therapeutics (PK) website address?
The website address for Endonovo Therapeutics (PK) is www.endonovo.com
Which industry sector does Endonovo Therapeutics (PK) operate in?
Endonovo Therapeutics (PK) operates in the ELECTROMEDICAL APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMPOQTempo Automation Holdings Inc (CE)
$ 0.01
(999,900.00%)
100
BLFEBioLife Sciences Inc (CE)
$ 0.005587
(558,600.00%)
501
MEDVFMedivolve Inc (CE)
$ 0.001
(99,900.00%)
333
PCIMFPacific Imperial Mines Inc (PK)
$ 0.0005
(49,900.00%)
400k
CLVRClever Leaves Holdings Inc (CE)
$ 0.025
(24,900.00%)
172
DBVTFDBV Technologies SA (PK)
$ 0.0001
(-99.95%)
139
RINORINO International Corp (CE)
$ 0.000001
(-99.93%)
200
GSVIGSV Inc (CE)
$ 0.000001
(-99.00%)
320
PLPLPlandai Biotechnology Inc (PK)
$ 0.000001
(-99.00%)
1.75M
FBECFBEC Worldwide Inc (CE)
$ 0.000001
(-99.00%)
24.13k
DPLSDarkPulse Inc (PK)
$ 0.0002
(-33.33%)
380.65M
GTCHGBT Technologies Inc (PK)
$ 0.0001
(0.00%)
175.21M
LTNCLabor Smart Inc (PK)
$ 0.0031
(287.50%)
154.36M
PSWWPrincipal Solar Inc (PK)
$ 0.0003
(0.00%)
140.54M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0011
(-8.33%)
130.23M

ENDV Discussion

View Posts
John_Vallay John_Vallay 3 weeks ago
To All The Nay Sayers that criticize on this board and all other boards I post on - I am ALWAYS proven right.

And YES, I am smarter than most people that criticize me on these boards.

The reason I am smarter is due to some very simple Investment 101 factors: (1) anytime a public company with a market cap less than $500 million has to raise capital they will have dilution and that always leads to lower stock price, (2) when a public company does not have funds invested it means the company should not be public, (3) ALL reverse mergers and SPACS have a never-ending stock price decline among a few other Investment 101 factors.

AND YES - I am always right when the top 3 Investment 101 Factors are adhered to.
AND YES - I make a very good living with my business and even more money investing in small and micro cap companies, but most of my profits are through short positions.
AND YES - I have lost money on some of my investments, but I would say 1 out of 10 investments is a loss, 9 out of 10 is a profit.
AND YES - I pay real taxes that include short term profit taxes on investments.
AND YES - I hope to pay twice as much in taxes every year until I die.

AND NO, all the naysayers that have and will continue to criticize me do not bother or upset me. I try really hard when I post on these boards to let people know about their investment and monies that they are likely to lose because of the 3 investment 101 factors.

I like to think I bring value and can save people money.
😂 1
Biotech_Tradez Biotech_Tradez 4 weeks ago
Probably a scientific advisor. Remember when Ira joined and they started pushing out a bunch of PR's with advisors and endorsers? Probably one of them.
👍️0
Craig305 Craig305 4 weeks ago
I don't see her name in the financials as to being a consultant or investor. Wonder what her claim is about. 
👍️0
Biotech_Tradez Biotech_Tradez 4 weeks ago
Another lawsuit from a past consultant. Julie Nicoletta, looks to be a pediatric nephrologist that was hired by endv and never paid. This one names ENDV, Collier and Ira Wiesberg as defendants. This one is scheduled for a non-jury trial in October. Looks like the list is growing by the day.

https://unicourt.com/case/ca-la15-caseao947cdc6470c1-355630?init_S=csup_ltst

I believe Collier is on the hook for some of the companies debt to eagle equities from when they acquired these PEMF patents and as soon as that debt is converted and sold into the market he will declare this BK and look to either steal the assets or sell it to Ira and get a kickback.
👍️0
richme richme 4 weeks ago
You probably do not do it but others seize upon your assessments and broadcast them all over the place, i.e., TWOH and possibly DTREF. I will check all posts from certainly super hypers and see if they mention your firm.
Just to see if it is a coincidence or if it goes beyond a coincidence. There are few coincidences in the OTC to be sure. May people lose big time, me included, while super hypers make a killing.
👍️0
Craig305 Craig305 4 weeks ago
100% there is. Company has no sales and has to settle a lawsuit with issued shares. At this share price, Billions of shares are needed to settle.
👍️0
CMsixfigures CMsixfigures 4 weeks ago
any dilution here?
👍️0
Acme Investments Acme Investments 1 month ago
I think the season of bashing is coming to an end!! Better find a hole to hibernate!!
🤢 1 🤪 1
Rainer Rainer 1 month ago
nice buys
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
20 million shares dumped into the bid. YIKES!

Looks like the dilution is now back on.
👍️0
Craig305 Craig305 2 months ago
A growing list of lawsuits from past consultants and investors. I'm sure this will not be the last one.May need to declare bankruptcy and close up shop to avoid the future incoming flow of other lawsuits.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
New lawsuit against ENDV: Nicoletta v. Endonovo Therapeutics, Inc

Looks like they are being sued by an orthopedic surgeon, Robert J. Nicoletta, MD they got an investment from and were not able to pay back.

https://www.pacermonitor.com/public/case/58060627/Nicoletta_v_Endonovo_Therapeutics,_Inc
👍️0
retired early retired early 2 months ago
Our prayer to the heroic nude mouse that gave a leg to science They tried to regrow the stump of a limb but nothing sprouted out and after all that time, the severed limb was too rotted to re-attach I imagine. :).
👍️0
Craig305 Craig305 2 months ago
One can look at the latest quarterly financials and see the shares that are being issued to settle the $2.2M lawsuit.To put it in perspective, 108,693,000 were issued at a SP value of .00005 ($5,435).108.6 million shares issued to pay $5.5k.Can you see how many Billions will need to be issued? 😲
👍️0
Craig305 Craig305 2 months ago
It is going to be very difficult to generate some volume so that the company that is owed $2M can dump their shares into the float. At current SP, there are still a few Billion shares needed to make up the settlement.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
New Quarterly Report out. $0 Revenue. $18 in cash. $16.3 million in liabilities.

Company is officially a carcass. Not long before the vultures finish picking it apart. I hope nobody is long on this piece of shit.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
These guys are more likely to file for bankruptcy than do anything they lied about in a PR.

Collier simply is an incompetent crook. He is running a penny stock scam that has run its course. There isn't a thing he could put out that anyone would believe anymore. He doesn't even have cash to put out a bunch of pump and dump press releases.

Do you really think they are going to acquire that construction company given they have a negative bank account balance? Do you really think they are going to sell their assets to a NASDAQ company for over $75 million given their current valuation? These are pathetic lies for pathetic people. You would have to be a moron to believe it.
👍️0
Craig305 Craig305 2 months ago
ENDV produced a road map in 2023 for milestones to reach in 2024.Not one milestone has been reached.I suppose the outstanding lawsuit settlement (and maybe multiple settlements) have put a damper on ENDV being able to financially achieve anything. 
👍️0
Biotech_Tradez Biotech_Tradez 4 months ago
I wonder how many shares Trillium has converted at $0.00005 and sold to these suckers.

Forget about the 2's, people bought at 3 and thought it was going up more not realizing that there is a diluter converting at $0.00005 and dumping into the volume.

My take is these idiots deserve what they get because they didn't even bother to read the sticky on the stock to know why it is this "cheap," or read the annual report to know that the company has no cash, no assets, and no revenue.

Also, OTCMarkets has placed a "SHELL RISK" warning on the ticker symbol because it has all the characteristics of a shell company, i.e. no assets, revenue and limited filings.
👍 1
Craig305 Craig305 4 months ago
All the people that bought the 2s are trapped. They were not able to sell at 3 and now 2s are back on the Ask. They may have to take a 50% loss or hope that a new pump can buy their 2s back for break even. 
👍️0
Biotech_Tradez Biotech_Tradez 4 months ago
New pump and dump crew buying up all the dilution. GLTA
👍️0
firebag1 firebag1 4 months ago
ADDED TOO - GLTYA
👍️0
Biotech_Tradez Biotech_Tradez 4 months ago
OTC Markets has added a "Shell Risk" to this ticker.

No assets tons of liabilities, faint disclosure and no revenue.
👍️0
Rainer Rainer 4 months ago
added... GLTA
👍️0
Biotech_Tradez Biotech_Tradez 4 months ago
1.2 billion O/S and looks like they are selling them!
👍️0
ScambusterBrown ScambusterBrown 4 months ago
Don't give all the credit to Alan Collier. His partner in crime is Garry Kann aka Garry Michael Kann who lost his broker license years ago, filed bankruptcy, defrauded investors, and has been running scams on both coasts since the early 1990s under many business names. Collier and Kann are two cons in a pod. They should be in prison for the level of fraud they have perpetrated.
👍 1
Biotech_Tradez Biotech_Tradez 4 months ago
"The company has or shortly will have judgements totaling approximately $400,000"

Expect more dilution to pay for these new lawsuits they are going to lose.

$3 in the bank, no real assets and 20 million in liabilities.
👍️0
Craig305 Craig305 4 months ago
Annual report released.
$0 sales in Q4. Total annual sales in 2024 was $10K
The 8-K with Evermed assisting with sales was supposed to bring in $168K in 2024.
The deal with Evermed appears to be non-existent.
👍️0
Craig305 Craig305 4 months ago
The Annual report is now released. You can see the conversion of the shares at .00005. Yikes. It will take Billions upon Billions of shares to repay the settlement.
👍️0
Biotech_Tradez Biotech_Tradez 4 months ago
160 million shares converted this week.

New O/S is 1,097,921,313

Not long until they run out of shares to print and have to reverse the stock again.
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
LOL, PATHETIC ATTEMPT TO KEEP THE STOCK AFLOAT.

Hundreds of millions of shares have probably been converted at $0.00005 and are being dumped, per the lawsuit they lost.

Funny how they don't put out bad news in PR's and 8K's but rather bury it in the footnotes of their financials.

This company is going into bankruptcy, it has no money to do anything, its bank account was overdrawn in its last quarterly report. The CEO has been fleecing shareholders for about a decade now and has never accomplished anything that has resulted in shareholder value. Their spin out is dead because they have no way to justify a bloated valuation let alone convince investors to put up north of $15 million to meet the initial listing requirements on NASDAQ.

This stock is going to need a reverse stock split pretty soon based on the rate of conversions and dilution.

This is basically the CEO going on another pump scheme to keep from having to shut this piece of shit down and go out and get a real job.
👍️0
Rainer Rainer 5 months ago
$ENDV Thank you to all our shareholders for your continued support.

We have several important updates coming which will be released as soon as possible via PR’s and 8k’s.— Endonovo Therapeutics, Inc. (@EndonovoInc) February 27, 2025
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
BUYER BEWARE: BIG CONVERSIONS AT $0.00005 UPCOMING!!

My target price of $0.0001 (Par Value) has been hit and now conversions will be done at below par value!

We may have massive dilution next week.
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
84.5 Million shares added last week! Yikes!!!

938,237,313 shares outstanding. Looks like the fire sale at ENDV continues. Not long before this thing hits the floor.
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
And here we go!! 90 million shares dumped on the bid.

RUN!!!!!!
👍️0
Closerlook Closerlook 5 months ago
The sub-penny OTC market is dying. Program buys and sells make it look like something is here but everyone is moving to crypto.
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
70 Million shares added this week!

New O/S is 853,720,313. Expect some big dumps on the bid next week.

Collier is awful quiet about his penny stock scam circling the drain. He can't even think up a new lie to pump his stock price anymore. That or like I stated, he wants it to tank so that he can give himself a bonus and screw his investors over once and for all before he reverses the stock.
👍️0
Craig305 Craig305 5 months ago
We have been telling you....they lost a lawsuit....Billions will be diluted. 
The strongest trouts could not swim upstream against the dilution that will be continuing for some time.
👍️0
Alley-oop Alley-oop 5 months ago
Shits are diluting this.
👍️0
brojazzy brojazzy 5 months ago
Ouch, this "stock" is dog shit, is mgmt in prison yet?
👍️0
Biotech_Tradez Biotech_Tradez 5 months ago
BUYER BEWARE: New Target Stock Price is $0.0001

Given that Trillium has the ability to convert at 50% discount to market their next conversions will be at $0.0001 or par value. As was predicted in my post below, the market price converges toward the conversion price and following conversions is driven down 50%, essentially it is a death spiral.

My other warning is that this company only has 2.5 billion authorized shares and is already at north of 800 million shares before we get conversions. I also want to point out that I have a very strong hunch that the CEO will give himself a massive bonus in the form of shares as soon as the stock price reaches par value ($0.0001). I predict somewhere in the neighborhood of $50,000 of stock at par value or 500 million shares before he decides to reverse the stock and repeat this scam as he has already done this to shareholders.

So my warning and predictions are as follows:

1.) Stock price goes to $0.0001 or less
2.) CEO gives himself a large bonus at par value or less (maybe 500 million shares)
3.) Reverse stock split at 1 for 1,000 like the last time.

You have been warned. Please feel free to post this as a sticky.
👍️0
Biotech_Tradez Biotech_Tradez 6 months ago
LOL, thanks for letting us know your opinions will only be to pump the stock.
💯 1
Alley-oop Alley-oop 6 months ago
That is really good news. Who cares if the company is bankrupt or not. It is already trading low. 
👍️0
Biotech_Tradez Biotech_Tradez 6 months ago
This company is heading for bankruptcy, RUN!!!!
💯 1
Alley-oop Alley-oop 6 months ago
Good job!
👍️0
Craig305 Craig305 6 months ago
97 Million shares added to the float in the past week. 
22% increase. 
👍️0
Biotech_Tradez Biotech_Tradez 6 months ago
LOL, you can't make this shit up!
👍️0
Craig305 Craig305 6 months ago
Are you aware that ENDV lost a lawsuit and there will be a minimum of 4 Billion shares added to the float?  The plantiff will just unload their shares on a high volume day.
It will be extremely difficult for this to have any significant rise in SP.
💯 1
Gladiator 83 Gladiator 83 6 months ago
Now it's time for good news.
👍️0
Craig305 Craig305 6 months ago
Since you are keeping watch on the share structure, you will notice that from Jan 3 to Jan 10, the unrestricted shares increased by 86 million shares. An increase of 24% in just 1 week. 😯 
👍️0

Your Recent History

Delayed Upgrade Clock